Department of Neurology, Washington University School of Medicine, Campus Box 8111, 660 South Euclid Ave, St Louis, MO, 63110, USA.
Department of Psychiatry, Washington University in St. Louis, Campus Box 8134, 4525 Scott Avenue, St Louis, MO, 63110, USA.
Orphanet J Rare Dis. 2019 Aug 2;14(1):188. doi: 10.1186/s13023-019-1160-z.
Wolfram syndrome is a rare disorder associated with diabetes mellitus, diabetes insipidus, optic nerve atrophy, hearing and vision loss, and neurodegeneration. Sleep complaints are common but have not been studied with objective measures. Our goal was to assess rates of sleep apnea and objective and self-reported measures of sleep quality, and to determine the relationship of sleep pathology to other clinical variables in Wolfram syndrome patients.
Genetically confirmed Wolfram syndrome patients were evaluated at the 2015 and 2016 Washington University Wolfram Syndrome Research Clinics. Patients wore an actigraphy device and a type III ambulatory sleep study device and completed the Epworth Sleepiness Scale (ESS), the Pittsburgh Sleep Quality Index (PSQI) and/or the Pediatric Sleep Questionnaire (PSQ). PSQI and PSQ questionnaire data were compared to a previously collected group of controls. Patients were characterized clinically with the Wolfram Unified Rating Scale (WURS) and a subset underwent magnetic resonance imaging (MRI) for brain volume measurements.
Twenty-one patients were evaluated ranging from age 8.9-29.7 years. Five of 17 (29%) adult patients fit the criteria for obstructive sleep apnea (OSA; apnea-hypopnea index [AHI] ≥ 5) and all 4 of 4 (100%) children aged 12 years or younger fit the criteria for obstructive sleep apnea (AHI's ≥ 1). Higher AHI was related to greater disease severity (higher WURS Physical scores). Higher mixed apnea scores were related to lower brainstem and cerebellar volumes. Patients' scores on the PSQ were higher than those of controls, indicating greater severity of childhood obstructive sleep-related breathing disorders.
Wolfram syndrome patients had a high rate of OSA. Further study would be needed to assess how these symptoms change over time. Addressing sleep disorders in Wolfram syndrome patients would likely improve their overall health and quality of life.
Wolfram 综合征是一种罕见的疾病,与糖尿病、尿崩症、视神经萎缩、听力和视力丧失以及神经退行性变有关。睡眠问题很常见,但尚未通过客观测量进行研究。我们的目标是评估睡眠呼吸暂停的发生率以及睡眠质量的客观和自我报告测量值,并确定睡眠病理学与 Wolfram 综合征患者其他临床变量的关系。
在 2015 年和 2016 年的华盛顿大学 Wolfram 综合征研究诊所,对经基因证实的 Wolfram 综合征患者进行了评估。患者佩戴活动记录仪和 III 型动态睡眠研究设备,并完成了 Epworth 嗜睡量表(ESS)、匹兹堡睡眠质量指数(PSQI)和/或儿科睡眠问卷(PSQ)。PSQI 和 PSQ 问卷数据与之前收集的一组对照组进行了比较。患者的临床特征采用 Wolfram 统一评分量表(WURS)进行描述,其中一部分患者接受了磁共振成像(MRI)进行脑容量测量。
共评估了 21 例患者,年龄 8.9-29.7 岁。17 例成年患者中有 5 例(29%)符合阻塞性睡眠呼吸暂停(OSA;呼吸暂停低通气指数 [AHI]≥5)标准,4 例 12 岁或以下的儿童均符合阻塞性睡眠呼吸暂停(AHI≥1)标准。更高的 AHI 与更高的疾病严重程度(更高的 WURS 身体评分)相关。更高的混合性呼吸暂停评分与更低的脑桥和小脑体积相关。患者的 PSQ 评分高于对照组,表明儿童阻塞性睡眠相关呼吸障碍的严重程度更高。
Wolfram 综合征患者的 OSA 发生率较高。需要进一步研究以评估这些症状随时间的变化。解决 Wolfram 综合征患者的睡眠障碍可能会改善他们的整体健康和生活质量。